publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
crystal
structur
catalyt
domain
clostridium
perfringen
neuraminidas
complex
noncarbohydratebas
inhibitor
cyclohexylamino
ethanesulfon
acid
b
r
c
antibacteri
antivir
neuraminidas
agent
inhibit
neuraminidas
activ
catalyz
hydrolysi
termin
nacetylneuramin
acid
glycoconjug
help
prevent
host
pathogenesi
lead
fatal
infecti
diseas
includ
influenza
bacteremia
sepsi
cholera
emerg
antibiot
drug
resist
commonli
use
antineuraminidas
agent
oseltamivir
tamiflu
zanamivir
relenza
highlight
need
develop
new
antineuraminidas
drug
obtain
serendipit
complex
crystal
catalyt
domain
clostridium
perfringen
neuraminidas
cpnani
cd
cyclohexylamino
ethanesulfon
acid
che
buffer
report
crystal
structur
cpnani
cd
complex
che
resolut
amphipath
che
bind
catalyt
site
cpnani
cd
similar
substrat
bind
site
acid
moieti
cyclohexyl
group
che
interact
cluster
three
arginin
residu
hydrophob
pocket
cpnani
cd
catalyt
site
addit
structur
comparison
bacteri
human
neuraminidas
suggest
che
could
serv
scaffold
develop
new
antineuraminidas
agent
target
cpnani
neuraminidas
express
mani
bacteria
includ
clostridium
perfringen
cp
streptococcu
pneumonia
sp
pseudomona
aeruginosa
virus
includ
influenza
b
neuraminidas
catalyz
hydrolyt
remov
termin
nacetylneuramin
acid
number
glycoconjug
play
pivot
role
human
infect
viral
neuraminidas
cleav
termin
cellular
receptor
newli
replic
viral
particl
attach
thu
neuraminidas
involv
viral
replic
name
releas
host
cell
meanwhil
bacteri
neuraminidas
function
initi
stage
pulmonari
infect
particip
biofilm
format
play
import
role
bacteri
growth
colon
thu
neuraminidas
pathogen
bacteria
virus
consid
promis
drug
target
prevent
infect
caus
fatal
human
diseas
influenza
bacteremia
sepsi
cholera
food
poison
ga
gangren
sever
antineuraminidas
agent
substrat
mimic
cyclopentan
pyrrolidinebas
deriv
ethanesulfon
acid
deriv
natur
compound
use
drug
develop
commerci
antibiot
antivir
agent
includ
oseltamivir
tamiflu
zanamivir
relenza
develop
prevent
bacteri
viral
infect
even
though
variou
commerci
drug
avail
market
emerg
resist
antibiot
antivir
drug
resist
mandat
develop
new
drug
cyclohexylamino
ethanesulfon
acid
che
commonli
use
buffer
agent
approxim
crystal
structur
complex
che
avail
protein
data
bank
pdb
che
bind
activ
site
sever
enzym
includ
neuraminidas
nanb
streptococcu
pneumonia
spnanb
pdb
code
papain
like
proteas
sever
acut
respiratori
syndrom
coronaviru
sarscov
pdb
code
sulfotransferas
pdb
code
sirtuin
pdb
code
haloalkalo
acid
dehalogenas
phosphatas
pdb
code
action
inhibit
substrat
bind
enzymat
activ
data
suggest
che
may
serv
scaffold
new
drug
develop
modul
enzym
function
che
contain
hydrophil
taurin
acid
moieti
hydrophob
cyclohexyl
group
amphipath
properti
che
rais
possibl
chesbas
develop
antineuraminidas
agent
catalyt
site
neuraminidas
compris
hydrophil
residu
arginin
cluster
three
arginin
residu
catalyt
aspart
residu
hydrophob
pocket
clostridium
perfringen
major
pathogen
caus
ga
gangren
enterotoxemia
human
three
neuraminidas
includ
nanh
nani
nanj
cpnani
secret
exosialidas
evalu
potenti
drug
target
inhibit
human
infect
caus
clostridium
perfringen
obtain
serendipit
complex
crystal
catalyt
domain
cpnani
cpnani
cd
che
serv
buffer
report
crystal
structur
cpnani
cd
complex
che
cpnani
cd
che
resolut
basi
structur
comparison
bacteri
human
neuraminidas
propos
che
could
serv
scaffold
develop
antineuraminidas
agent
target
cpnani
clone
express
purif
cpnani
cd
residu
report
previous
briefli
recombin
cpnani
cd
direct
ctermin
hexahistidin
tag
fusion
express
escherichia
coli
codonplu
cell
protein
purifi
use
ninta
affin
chromatographi
column
elut
buffer
consist
mm
sodium
phosphat
ph
mm
nacl
mm
imidazol
protein
subject
size
exclus
chromatographi
hiload
superdex
column
ge
healthcar
life
scienc
preequilibr
gelfiltr
buffer
mm
cheshcl
ph
mm
nacl
protein
concentr
mgml
use
amicon
ultra
k
millipor
store
c
crystal
perform
hangingdrop
vapordiffus
method
welldiffract
cocryst
grown
c
ml
drop
contain
equal
volum
protein
solut
mm
cheshcl
ph
mm
nacl
mother
liquor
reservoir
compris
wv
peg
ammonium
sulfat
crystal
cryoprotect
cryoprotect
contain
wv
peg
vv
glycerol
ammonium
sulfat
flashfrozen
liquid
nitrogen
data
collect
data
set
cpnani
cd
che
complex
collect
use
adsc
detector
beamlin
pohang
acceler
laboratori
pal
republ
korea
use
xray
beam
singl
wavelength
diffract
data
process
scale
use
softwar
cpnani
cd
che
cocryst
diffract
resolut
belong
space
group
cell
paramet
b
c
b
two
molecul
cpnani
cd
che
complex
present
asymmetr
unit
matthew
coeffici
v
calcul
da
correspond
solvent
content
structur
cpnani
cd
che
complex
solv
molecular
replac
method
molrep
softwar
use
apostructur
cpnani
cd
pdb
code
search
model
autom
ligand
build
che
ligand
id
nhe
structur
carri
use
phenixligandfit
cycl
manual
rebuild
perform
use
coot
softwar
subsequ
refin
carri
use
phenixrefin
final
crystallograph
r
valu
r
free
composit
omit
map
mf
df
c
che
contour
gener
softwar
weak
electron
densiti
region
residu
exclud
final
structur
ramachandran
statist
calcul
use
program
molprob
show
residu
torsion
angl
forbidden
area
residu
favor
region
residu
allow
region
data
collect
tabl
data
collect
refin
statist
valu
parenthes
highest
resolut
shell
intens
reflect
h
p
h
sum
reflect
model
structur
human
neuraminidas
built
use
structur
templat
human
pdb
code
model
softwar
describ
previou
studi
crystal
structur
cpnani
cd
che
determin
resolut
rfactor
free
rfactor
molecular
replac
use
cpnani
cd
apo
structur
pdb
code
templat
tabl
crystal
cpnani
cd
che
contain
two
molecul
asymmetr
unit
root
mean
squar
deviat
rmsd
c
atom
overal
structur
cpnani
cd
che
complex
show
sixblad
bpropel
fold
argilepro
rip
aspbox
motif
also
catalyt
site
includ
arginin
cluster
catalyt
aspart
glutam
tyrosin
neuraminidas
rang
bacteria
virus
human
fig
che
compris
hydrophil
taurin
acid
moieti
hydrophob
cyclohexyl
group
bind
center
catalyt
site
fig
c
sulfon
acid
group
che
form
direct
hydrogen
bond
side
chain
arginin
cluster
secondari
amin
che
also
interact
thu
form
direct
hydrogen
bond
well
hydrogen
bond
mediat
water
molecul
cyclohexyl
group
che
interact
residu
hydrophob
pocket
bcarbon
side
chain
fig
thu
function
group
che
includ
sulfon
acid
secondari
amin
cyclohexyl
group
strongli
contribut
tight
interact
cpnani
cd
cpnani
cd
che
structur
similar
apoform
form
rmsd
among
c
atom
respect
fig
detail
view
howev
torsion
angl
residu
catalyt
site
differ
among
three
structur
fig
take
advantag
high
resolut
structur
confid
analyz
multipl
conform
side
chain
apoform
acidbas
catalyst
dual
conform
meanwhil
complex
side
chain
adopt
singl
conform
form
stabl
hydrogen
bond
group
case
che
complex
form
conform
similar
substratebound
structur
interact
secondari
amin
che
fig
residu
behav
differ
three
structur
side
chain
cpnaniapo
dual
conform
conform
interact
fig
complex
side
chain
also
dual
conform
nevertheless
posit
differ
apo
form
although
one
dual
conform
maintain
hydrophob
interact
conform
form
hydrophob
contact
acetamid
moieti
togeth
bcarbon
interest
note
che
complex
one
conform
one
interact
cyclohexyl
group
che
addit
water
molecul
che
complex
apoform
locat
posit
similar
group
interact
fig
b
evalu
structur
differ
complex
cpnani
cd
che
spnanb
cd
che
superimpos
complex
structur
che
molecul
locat
similar
posit
catalyt
site
cpnani
cd
spnanb
cd
interact
residu
includ
arginin
cluster
cpnani
cd
versu
spnanb
cd
catalyt
aspart
residu
cpnani
cd
versu
spnanb
cd
fig
note
water
molecul
bridg
hydrogen
bond
secondari
amin
che
cpnani
cd
spnanb
cd
respect
indic
water
molecul
play
indispens
role
che
bind
one
hand
residu
hydrophob
pocket
cpnani
cd
spnanb
cd
less
conserv
cpnani
spnanb
nevertheless
hydrophil
residu
arginin
cluster
catalyt
aspart
interact
acid
che
well
conserv
fig
compar
hydrophob
level
cyclohexylbind
pocket
cpnani
cd
spnanb
cd
calcul
hydrophob
pocket
area
use
softwar
deepview
found
hydrophob
contact
area
cpnani
cd
form
bcarbon
side
chain
two
fold
wider
spnanb
cd
form
bcarbon
side
chain
although
cyclohexyl
group
che
interact
similar
hydrophob
pocket
cpnani
cd
spnanb
cd
che
may
form
stronger
hydrophob
contact
cpnani
cd
spnanb
cd
wider
hydrophob
contact
area
among
four
human
neuraminidas
structur
alreadi
report
pdb
code
model
human
report
previou
studi
fig
cpnani
cd
che
structur
hydrophob
pocket
residu
contribut
stabl
interact
cyclohexyl
group
che
human
neuraminidas
howev
hydrophob
pocket
includ
polar
residu
thu
predict
hydrophob
interact
che
human
neuraminidas
less
stabl
addit
che
interact
cpnani
cd
interact
mediat
one
water
molecul
hand
residu
correspond
cpnani
cd
conserv
watermedi
hydrogen
bond
che
may
differ
human
neuraminidas
collect
data
suggest
che
interact
less
favor
human
neuraminidas
less
hydrophob
interact
cyclohexyl
group
che
absenc
watermedi
hydrogen
bond
secondari
amin
che
compar
cpnani
cd
che
structur
structur
bacteri
viral
neuraminidas
complex
oseltamivir
zanamivir
fig
structur
comparison
human
structur
abl
suggest
strategi
modif
che
facilit
develop
new
antineuraminidas
agent
target
cpnani
che
contain
sulfon
acid
group
show
bind
similar
carboxyl
group
oseltamivir
zanamivir
interact
arginin
cluster
catalyt
site
fig
b
nonetheless
lack
hydrophil
function
group
side
chain
group
group
oseltamivir
group
zanamivir
thu
addit
glycerol
group
che
hydrophil
group
hydroxyl
amino
guanidin
group
nitrogen
che
may
replac
water
molecul
bridg
hydrogen
bond
che
may
enhanc
interact
che
residu
cpnani
cd
fig
moreov
introduct
addit
moieti
cyclohexyl
ring
che
report
increas
inhibitori
effect
spnanb
thu
propos
addit
hydrophob
moieti
linear
hydrophob
group
hydrophob
pentyloxi
substitu
posit
cyclohexyl
substitu
aryl
group
phenyl
benzyl
cycloalkan
function
group
cycloheptyl
cyclooctyl
che
enhanc
hydrophob
interact
well
pp
stack
hydrophob
pocket
bacteri
neuraminidas
catalyt
site
addit
predict
addit
hydrophob
moieti
cyclohexyl
group
would
also
block
fig
structur
comparison
catalyt
domain
clostridium
perfringen
nani
cpnani
cd
human
neuraminidas
stereoview
superimpos
structur
cpnani
cd
che
cyan
catalyt
domain
human
pdb
code
brown
green
pink
yellow
structur
human
model
use
human
templat
see
materi
method
che
residu
water
molecul
display
stick
model
sphere
respect
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
interact
human
neuraminidas
cyclohexyl
group
che
bind
less
conserv
hydrophob
pocket
thu
possibl
design
specif
inhibitor
cpnani
mean
che
target
less
conserv
hydrophob
pocket
catalyt
site
basi
structurebas
compar
analys
bacteri
human
neuraminidas
suggest
strategi
modif
che
develop
specif
antineuraminidas
agent
target
cpnani
author
declar
conflict
interest
thank
staff
beamlin
pohang
acceler
laboratori
pohang
south
korea
beamlin
photon
factori
tsukuba
japan
beamlin
harima
japan
kind
help
data
collect
work
support
kribb
research
initi
program
nation
research
foundat
korea
nrf
grant
supplementari
data
relat
articl
found
http
transpar
document
relat
articl
found
onlin
http
